BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20598436)

  • 1. Salvage radiotherapy after high-intensity focussed ultrasound for recurrent localised prostate cancer.
    Riviere J; Bernhard JC; Robert G; Wallerand H; Deti E; Maurice-Tison S; Ardiet JM; Maire JP; Richaud P; Ferriere JM; Ballanger P; Gelet A; Pasticier G
    Eur Urol; 2010 Oct; 58(4):567-73. PubMed ID: 20598436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-intensity focused ultrasound: a potential salvage treatment for recurrent prostate cancer following radiotherapy.
    Acher PL; Thwaini A; Shergill IS; Barua JM
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):969-70. PubMed ID: 16831068
    [No Abstract]   [Full Text] [Related]  

  • 3. [Salvage treatments for prostatic radiation failure].
    Baumert H
    Cancer Radiother; 2010 Oct; 14(6-7):442-5. PubMed ID: 20801701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage high-intensity focused ultrasound for biopsy-confirmed local recurrence of prostate cancer after radical prostatectomy.
    Murota-Kawano A; Nakano M; Hongo S; Shoji S; Nagata Y; Uchida T
    BJU Int; 2010 Jun; 105(12):1642-5. PubMed ID: 19922544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after external beam radiation, brachytherapy or proton therapy.
    Uchida T; Shoji S; Nakano M; Hongo S; Nitta M; Usui Y; Nagata Y
    BJU Int; 2011 Feb; 107(3):378-82. PubMed ID: 21265984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage radiotherapy after high-intensity focused ultrasound for localised prostate cancer--a case report.
    Mitchell DM; Alam N; Rajpal S; Brown S; Taylor MB; Logue JP
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):200. PubMed ID: 18024094
    [No Abstract]   [Full Text] [Related]  

  • 7. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.
    Murat FJ; Poissonnier L; Rabilloud M; Belot A; Bouvier R; Rouviere O; Chapelon JY; Gelet A
    Eur Urol; 2009 Mar; 55(3):640-7. PubMed ID: 18508188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current role of high-intensity focused ultrasound for the management of radiation-recurrent prostate cancer.
    Sountoulides P; Theodosiou A; Finazzi-Agró E
    Expert Rev Med Devices; 2012 Jul; 9(4):401-8. PubMed ID: 22905844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage laparoscopic extraperitoneal radical prostatectomy after failed high-intensity focused ultrasound and radiotherapy for localized prostate cancer.
    Stolzenburg JU; Bynens B; Do M; Rabenalt R; Katsakiori PF; Liatsikos E
    Urology; 2007 Nov; 70(5):956-60. PubMed ID: 17919699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy.
    Kimura M; Mouraviev V; Tsivian M; Mayes JM; Satoh T; Polascik TJ
    BJU Int; 2010 Jan; 105(2):191-201. PubMed ID: 19583717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HIFU in salvage treatment of patients with prostate cancer after primary external radiation therapy--status 2012].
    Baumunk D; Cash H; Ebbing J; Porsch M; Janitzky A; Wendler JJ; Liehr UB; Ganzer R; Blana A; Schostak M
    Aktuelle Urol; 2012 Sep; 43(5):330-6. PubMed ID: 22875633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer.
    Ganzer R; Rogenhofer S; Walter B; Lunz JC; Schostak M; Wieland WF; Blana A
    Eur Urol; 2008 Mar; 53(3):547-53. PubMed ID: 17662520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial comment on: Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.
    de la Rosette JJ
    Eur Urol; 2009 Mar; 55(3):647-8. PubMed ID: 18508190
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment on: Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.
    Cestari A; Guazzoni G
    Eur Urol; 2009 Mar; 55(3):648-9. PubMed ID: 18508189
    [No Abstract]   [Full Text] [Related]  

  • 15. Six years' experience with high-intensity focused ultrasonography for prostate cancer: oncological outcomes using the new 'Stuttgart' definition for biochemical failure.
    Ripert T; Azémar MD; Ménard J; Barbe C; Messaoudi R; Bayoud Y; Pierrevelcin J; Duval F; Staerman F
    BJU Int; 2011 Jun; 107(12):1899-905. PubMed ID: 21083637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
    Lee HM; Hong JH; Choi HY
    Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Locally recurrent prostatic adenocarcinoma after exclusive radiotherapy: results of high intensity focused ultrasound].
    Poissonnier L; Murat FJ; Belot A; Bouvier R; Rabilloud M; Rouviere O; Chapelon JY; Gelet A
    Prog Urol; 2008 Apr; 18(4):223-9. PubMed ID: 18501302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anterior perirectal fat tissue thickness is a strong predictor of recurrence after high-intensity focused ultrasound for prostate cancer.
    Sumitomo M; Asakuma J; Yoshii H; Sato A; Horiguchi A; Ito K; Nagakura K; Asano T
    Int J Urol; 2010 Sep; 17(9):776-82. PubMed ID: 20569272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.
    Challacombe BJ; Murphy DG; Zakri R; Cahill DJ
    BJU Int; 2009 Jul; 104(2):200-4. PubMed ID: 19220245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy.
    Wong GW; Palazzi-Churas KL; Jarrard DF; Paolone DR; Graf AK; Hedican SP; Wegenke JD; Ritter MA
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):449-55. PubMed ID: 17869014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.